<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="4-part\PMC7291249\results\search\disease\results.xml">
  <result pre="Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Influenza viruses cause infectious" exact="respiratory disease" post="characterized by fever, myalgia, and congestion, ranging in severity"/>
  <result pre="life-threating. Although enormous efforts have aimed to prevent and treat" exact="influenza" post="infections, seasonal and pandemic influenza outbreaks remain a major"/>
  <result pre="aimed to prevent and treat influenza infections, seasonal and pandemic" exact="influenza" post="outbreaks remain a major public health concern. This is"/>
  <result pre="remain a major public health concern. This is largely because" exact="influenza" post="viruses rapidly undergo genetic mutations that restrict the long-lasting"/>
  <result pre="regimens. In this review, we discuss the virological features of" exact="influenza" post="A viruses and provide an overview of current knowledge"/>
  <result pre="overview of current knowledge of the innate sensing of invading" exact="influenza" post="viruses and the protective immune responses in the host."/>
  <result pre="influenza viruses and the protective immune responses in the host." exact="influenza" post="virus anti-influenza immune responses 1. Introduction The influenza virus,"/>
  <result pre="the host. influenza virus anti-influenza immune responses 1. Introduction The" exact="influenza" post="virus, or ‘flu’, causes an acute respiratory disease that"/>
  <result pre="1. Introduction The influenza virus, or ‘flu’, causes an acute" exact="respiratory disease" post="that results in moderate to severe symptoms including fever,"/>
  <result pre="muscle pain, headaches, and sometimes even death. Each year, seasonal" exact="influenza" post="strains spread across the globe, causing significant economic and"/>
  <result pre="Organization releases a recommendation for the composition of the seasonal" exact="influenza" post="vaccine each year on the basis of strains that"/>
  <result pre="several distinct steps of the viral replication cycle to inhibit" exact="influenza" post="propagation in hosts. Matrix 2 (M2) inhibitors block the"/>
  <result pre="endonuclease inhibitor, which received FDA approval for the treatment of" exact="influenza" post="in 2018 [2,3], targets the influenza polymerase acidic (PA)"/>
  <result pre="for the treatment of influenza in 2018 [2,3], targets the" exact="influenza" post="polymerase acidic (PA) endonuclease to prevent viral replication [4]."/>
  <result pre="symptoms by a few days. Additionally, constant mutations in the" exact="influenza" post="virus can result in resistance, thus reducing therapeutic efficacy."/>
  <result pre="result in resistance, thus reducing therapeutic efficacy. Throughout history, several" exact="influenza" post="pandemics have emerged as a result of cross-species transmission,"/>
  <result pre="was generated in 2009 after a reassortment event among H1N1" exact="influenza" post="subtypes in swine [5], and that virus subsequently spread"/>
  <result pre="young children, the elderly, and patients with comorbidities. Because seasonal" exact="influenza" post="mutations and cross-species events are relatively unpredictable, it is"/>
  <result pre="important to understand the factors that influence successful defense against" exact="influenza" post="infections. In this review, we describe the virological characteristics"/>
  <result pre="infections. In this review, we describe the virological characteristics of" exact="influenza" post="A viruses that facilitate viral propagation in host cells"/>
  <result pre="cells and the mechanisms by which host cells recognize invading" exact="influenza" post="viruses and produce a protective response against infection. 2."/>
  <result pre="against infection. 2. Virological Features of Influenza A Virus The" exact="influenza" post="virus is a respiratory pathogen that causes acute febrile"/>
  <result pre="is a respiratory pathogen that causes acute febrile disease called" exact="influenza" post="or flu. It belongs to the Orthomyxoviridae family and"/>
  <result pre="infect diverse host species including humans, pigs, and birds. The" exact="influenza" post="viruses that cause disease in humans are classified into"/>
  <result pre="differences in their NP and M proteins [7,8]. The novel" exact="influenza" post="D virus, which was first identified in 2011 [9],"/>
  <result pre="as cattle and pigs [10,11]. However, it remains unclear whether" exact="influenza" post="D virus (IDV) can cause disease in humans. While"/>
  <result pre="later in the season, is responsible for 15–30% of total" exact="influenza" post="infections [14]. While the disease severity due to both"/>
  <result pre="[15,16,17], IBV does not cause pandemics. In contrast, strains of" exact="influenza" post="A virus (IAV) are often responsible for seasonal influenza"/>
  <result pre="of influenza A virus (IAV) are often responsible for seasonal" exact="influenza" post="epidemics and pandemic outbreaks due to frequent genetic mutations"/>
  <result pre="shift, the primary mechanisms behind the antigenic variation of the" exact="influenza" post="virus, occur in both HA and NA. The accumulation"/>
  <result pre="and are capable of bypassing pre-existing adaptive immunity, to cause" exact="influenza" post="pandemics [22,23,24,25]. To achieve successful infection, the influenza virus"/>
  <result pre="to cause influenza pandemics [22,23,24,25]. To achieve successful infection, the" exact="influenza" post="virus must first pass through the respiratory mucus layer"/>
  <result pre="cells from infection by inhibiting viral entry [26]. However, the" exact="influenza" post="virus cleaves sialylated mucins using NA, which disables the"/>
  <result pre="and enter the host cell via receptor-mediated endocytosis. However, SIA-independent" exact="influenza" post="infection has also been reported [27,28]. C-type lectin receptors"/>
  <result pre="act as alternative receptors that allow infectious entry of the" exact="influenza" post="virus in a manner independent of SIA. The macrophage’s"/>
  <result pre="macrophage’s galactose-type lectin and mannose receptors play important roles in" exact="influenza" post="infection [29,30,31]. DC-SIGN (DC209) and L-SIGN (CD209L) have been"/>
  <result pre="[29,30,31]. DC-SIGN (DC209) and L-SIGN (CD209L) have been identified as" exact="influenza" post="attachment receptors [32,33,34,35], and the blocking of DC-SIGN decreases"/>
  <result pre="both transcription and replication of the viral RNA genome. The" exact="influenza" post="RdRP protein consists of three subunits: PB1, PB2, and"/>
  <result pre="it has been suggested that NS2 is important for efficient" exact="influenza" post="virion formation and budding due to its interactions with"/>
  <result pre="of the NLRP3-inflammasome [61]. Therapeutics targeting various stages of the" exact="influenza" post="virus’ replication cycle have been developed. There are three"/>
  <result pre="budding from host cells, and the cap-dependent endonuclease inhibitor targets" exact="influenza" post="polymerase to prevent viral replication. While these drugs are"/>
  <result pre="Sensors Recognizing the Influenza Virus After entering the host, the" exact="influenza" post="virus infects bronchiolar-alveolar epithelial cells lining the respiratory tract"/>
  <result pre="patterns (PAMPs) and initiate innate immune responses. Recognition of the" exact="influenza" post="virus is mediated by several types of PRRs, including"/>
  <result pre="produce dsRNA during replication [63,64], TLR3 activation can occur during" exact="influenza" post="infection [65]. However, the specific TLR3 ligand that is"/>
  <result pre="single-stranded RNA (ssRNA), is involved in the recognition of the" exact="influenza" post="virus [69]. Plasmacytoid DCs (pDCs) express TLR7 in their"/>
  <result pre="unclear whether TLR7-MyD88 signaling is necessary for the protection against" exact="influenza" post="infection. However, TLR7 deficiency results in attenuated production of"/>
  <result pre="TLR7 is responsible for efficient innate immune responses against the" exact="influenza" post="virus. Indeed, prior evidence has supported the function of"/>
  <result pre="proinflammatory cytokines and type I IFNs. Although replication of the" exact="influenza" post="virus occurs in the nucleus, the RIG-I signaling pathway"/>
  <result pre="for detection of viral ssRNA by RIG-I. Of note, the" exact="influenza" post="virus actually prevents the formation of these stress granules"/>
  <result pre="manner dependent on functional NS1 protein [78,79]. Taken together, the" exact="influenza" post="virus NS1 protein disrupts RIG-I signaling, thus suppressing IFN-α/β"/>
  <result pre="against viral infection; survival and adaptive immune responses against the" exact="influenza" post="virus were unchanged in MAVS-deficient mice relative to wild-type"/>
  <result pre="mediates production of the proinflammatory cytokines IL-1β and IL-18. Several" exact="influenza" post="virus proteins are associated with the activation of the"/>
  <result pre="inflammasome. For example, M2 protein, the proton channel of the" exact="influenza" post="virus, activates the formation of the NLRP3 inflammasome [71]."/>
  <result pre="in the Golgi apparatus is essential for inflammasome activation. Interestingly," exact="influenza" post="virus NS1 proteins inhibit the secretion of IL-1β through"/>
  <result pre="a crucial role for the inflammasome in cellular defense against" exact="influenza" post="virus infection. Inflammasome-deficient mice have impaired recruitment of monocytes"/>
  <result pre="the activation of T and B cell responses against the" exact="influenza" post="virus during low dose infection; deficiency of the inflammasome"/>
  <result pre="important role in the defense against DNA viruses including the" exact="herpes simplex" post="virus [92]. Interestingly, a recent study has revealed that"/>
  <result pre="an RNA virus, also activates the cGAS-STING pathway [93]. After" exact="influenza" post="virus infection, the M2 protein promotes the release of"/>
  <result pre="the cytosol, where it stimulates the cGAS pathway. Interestingly, the" exact="influenza" post="virus NS1 protein appears to associate with mtDNA and"/>
  <result pre="whether the cGAS-STING pathway is crucial for host survival after" exact="influenza" post="virus infection. 4. Innate Effector Cell Types in the"/>
  <result pre="Effector Cell Types in the Response to Influenza Infection During" exact="influenza" post="virus infections, innate signaling and adaptive immune responses both"/>
  <result pre="immune cells are responsible for both protection and immunopathology following" exact="influenza" post="virus infection. 4.1. Natural Killer Cells, Neutrophils, and Macrophages"/>
  <result pre="[101,102]. Defects in NK cells lead to increased susceptibility to" exact="influenza" post="infection and uncontrolled viral growth in the lungs [103,104]."/>
  <result pre="cell-induced inflammation can also contribute to pathology following high dose" exact="influenza" post="virus infection [105,106]. Neutrophils, monocytes, and macrophages inhibit the"/>
  <result pre="in animal studies showing that neutrophil depletion leads to increased" exact="influenza" post="mortality due to impaired viral clearance [109,110]. Neutropenic mice"/>
  <result pre="These studies indicate that neutrophils play a protective role in" exact="influenza" post="infection, but that excessive recruitment of neutrophils can also"/>
  <result pre="lines of evidence supporting the protective role of AMs during" exact="influenza" post="infection. Clodronate-induced depletion of AMs increases the mortality of"/>
  <result pre="increases the mortality of mice and enhances pulmonary inflammation during" exact="influenza" post="infection [116]. Csf2−/− mice, which are deficient in AM"/>
  <result pre="[116]. Csf2−/− mice, which are deficient in AM development, experience" exact="respiratory failure" post="and reduced resistance to influenza infection despite having normal"/>
  <result pre="in AM development, experience respiratory failure and reduced resistance to" exact="influenza" post="infection despite having normal adaptive immune responses against influenza"/>
  <result pre="to influenza infection despite having normal adaptive immune responses against" exact="influenza" post="virus [117]. Consistently, an AM depletion model in CD169-DTR"/>
  <result pre="led to aggressive inflammatory responses and severe lung pathology after" exact="influenza" post="infection [118]. AMs control lung dysfunction by increasing the"/>
  <result pre="AMs play a crucial role in maintaining pulmonary homeostasis during" exact="influenza" post="infection. 4.2. Dendritic Cells DCs, which belong to the"/>
  <result pre="have been conducted to clarify the role of DCs during" exact="influenza" post="virus infection. CD11c-DTR transgenic mice express a high-affinity diphtheria"/>
  <result pre="during influenza virus infection. CD11c-DTR transgenic mice express a high-affinity" exact="diphtheria" post="toxin receptor (DTR) in CD11c+ cells [120], allowing targeted"/>
  <result pre="[120], allowing targeted depletion of DCs by the administration of" exact="diphtheria" post="toxin (DT). CD11c-DTR mice have been used to study"/>
  <result pre="used to study the function of DCs in vivo. Following" exact="influenza" post="virus infection, DT-treated mice experience significantly more severe weight"/>
  <result pre="of CD8+ T cells and T cell-mediated viral clearance during" exact="influenza" post="virus infection. In the lungs, DCs are classified into"/>
  <result pre="various DC subsets have specialized functions in the response to" exact="influenza" post="virus infection. Remarkably, respiratory DC subsets display different susceptibility"/>
  <result pre="virus infection. Remarkably, respiratory DC subsets display different susceptibility to" exact="influenza" post="virus infection. cDC1 is more susceptible to influenza virus"/>
  <result pre="susceptibility to influenza virus infection. cDC1 is more susceptible to" exact="influenza" post="virus infection than cDC2 and pDCs [126], but influenza"/>
  <result pre="to influenza virus infection than cDC2 and pDCs [126], but" exact="influenza" post="infection of cDC1 does not lead to productive viral"/>
  <result pre="cDC1 does not lead to productive viral replication [127]. Following" exact="influenza" post="infection, lung-migratory cDCs take up viral antigen and migrate"/>
  <result pre="anti-influenza response. Most studies determining the role of DCs in" exact="influenza" post="virus infection have focused on the cDC1 subset. CD103+"/>
  <result pre="and this process reaches its peak within 48–72 h after" exact="influenza" post="virus infection [130]. There have been several reports that"/>
  <result pre="for activation of effective CD8+ T cell responses against the" exact="influenza" post="virus [121,127,131,132]. For example, Batf3−/− mice, which lack cDC1s"/>
  <result pre="lectin receptor-expressing cells such as cDC1, are highly susceptible to" exact="influenza" post="virus infection after treatment with DT [129]. These cDC1-depleted"/>
  <result pre="T cell proliferation and Th1 responses after stimulation with live-attenuated" exact="influenza" post="virus [134], indicating that cDC1 can be responsible for"/>
  <result pre="cDC2s in lymph nodes that drain from the lungs during" exact="influenza" post="virus infection, these cells rarely carried intact viral antigens"/>
  <result pre="the role of cDC1s and cDC2s in the response to" exact="influenza" post="virus infection. pDCs, which are primarily known as producers"/>
  <result pre="seem to play a minor role in the defense against" exact="influenza" post="virus infection. Despite the accumulation of pDCs in the"/>
  <result pre="infection. Despite the accumulation of pDCs in the lung following" exact="influenza" post="virus infection, pDC-depleted mice showed identical survival rate and"/>
  <result pre="loss, effector CD8+ T cell responses, or viral clearance after" exact="influenza" post="virus infection in mice [121]. Consistently, both wild-type and"/>
  <result pre="IkarosL/L mice showed comparable weight loss, viral burden in lung," exact="influenza" post="virus-specific antibody production, and lung pathology following viral infection"/>
  <result pre="[139]. However, there is some evidence that pDCs may cross-present" exact="influenza" post="virus antigens to CD8+ T cells [140,141]. Although the"/>
  <result pre="CD8+ T cells [140,141]. Although the role of MoDCs during" exact="influenza" post="virus infection has not been well established, it has"/>
  <result pre="reported that the number of CCR2-expressing MoDCs are increased in" exact="influenza" post="virus-infected lungs [124]. These cells induce the robust production"/>
  <result pre="pulmonary pathology, and mortality after a lethal dose of the" exact="influenza" post="virus. While the specific mechanisms remain unknown, these results"/>
  <result pre="remain unknown, these results indicate that MoDCs are associated with" exact="influenza" post="virus-induced pulmonary pathology. On the other hand, other work"/>
  <result pre="work has suggested a protective role for MoDCs during secondary" exact="influenza" post="virus infection [142]. Researchers found that MoDC-deficient CCR2−/− mice"/>
  <result pre="an impairment of antigen-specific CD8+ T cell formation following primary" exact="influenza" post="challenge, and lack of MoDCs during primary influenza infection"/>
  <result pre="following primary influenza challenge, and lack of MoDCs during primary" exact="influenza" post="infection reduced host resistance to secondary virus infection, suggesting"/>
  <result pre="suggesting that MoDCs could be considered as putative targets of" exact="influenza" post="vaccine. 5. Protective Adaptive Immune Responses against Influenza Infections"/>
  <result pre="from reinfection. As expected, immunodeficient mice that are infected with" exact="influenza" post="experience a significantly higher rate of mortality than healthy"/>
  <result pre="responses. CD4+ T cell responses peak at 10 days after" exact="influenza" post="infection in the mouse lung [145]. Adaptive transfer of"/>
  <result pre="of effector CD4+ T cells isolated from mice infected with" exact="influenza" post="lead to increased survival of recipient mice after influenza"/>
  <result pre="with influenza lead to increased survival of recipient mice after" exact="influenza" post="challenge [145]. The cytokine milieu generated during influenza virus"/>
  <result pre="mice after influenza challenge [145]. The cytokine milieu generated during" exact="influenza" post="virus infection is polarized to support the generation of"/>
  <result pre="mediate cellular immune responses. Th2 responses are also induced following" exact="influenza" post="virus infection. Th2 cells secrete IL-4, IL-5, and IL-13"/>
  <result pre="However, Th1 cells are more closely associated with survival after" exact="influenza" post="virus infection compared with Th2 cells [148]. Some CD4+"/>
  <result pre="role in host protection during and after infection with the" exact="influenza" post="virus. 5.2. Cytotoxic CD8+ T Cell Response CD8+ T"/>
  <result pre="cells are important for viral clearance and host protection during" exact="influenza" post="virus infection. CD8+ T cells recognize viral antigens loaded"/>
  <result pre="T cells, display delayed viral clearance and severe mortality following" exact="influenza" post="virus infection [155]. Activated cytotoxic CD8+ T cells (CTLs)"/>
  <result pre="for the regulation of pulmonary inflammation during the response to" exact="influenza" post="virus infections. Previous studies have suggested that CD8+ effector"/>
  <result pre="of IL-10 in the lungs of mice infected with the" exact="influenza" post="virus [161]. Further, blockade of IL-10 signaling increases pulmonary"/>
  <result pre="IL-10 signaling increases pulmonary inflammation and lethal injury following sublethal" exact="influenza" post="virus challenge [161]. 5.3. Humoral Immunity The protective role"/>
  <result pre="immune response has been extensively studied in recent years. During" exact="influenza" post="virus infection, naïve B cells in the mLNs encounter"/>
  <result pre="virus infection, naïve B cells in the mLNs encounter the" exact="influenza" post="virus antigen and differentiate into antibody-forming cells (AFCs). B"/>
  <result pre="cells (AFCs). B lymphocyte-deficient μMT mice are more susceptible to" exact="influenza" post="virus infection compared to wild-type mice [162,163]. The B"/>
  <result pre="compared to wild-type mice [162,163]. The B cell response against" exact="influenza" post="virus begins approximately 3 days after infection, and B"/>
  <result pre="days post-infection in mice [121]. In mice, the majority of" exact="influenza" post="virus antigen-specific AFCs in the lung produce IgG and"/>
  <result pre="their target [171]. In addition to the previously described functions," exact="influenza" post="virus-specific antibodies mediate antibody-dependent cell cytotoxicity and Fc receptor-mediated"/>
  <result pre="natural IgM, independent of antigenic priming, contribute to protection against" exact="influenza" post="virus infection. Natural IgM in the airway has neutralizing"/>
  <result pre="health burden. Further, the average annual total economic burden of" exact="influenza" post="has been estimated at $11.2 billion in the United"/>
  <result pre="burden of influenza. Vaccination remains the best way to prevent" exact="influenza" post="infection. Flu vaccines contain virus strains that are expected"/>
  <result pre="vaccination can provide effective protection against viral infection. However, because" exact="influenza" post="viruses constantly change their antigens to escape from vaccine-induced"/>
  <result pre="a new flu vaccine each year. A long-standing goal of" exact="influenza" post="research is the development of universal vaccines that provide"/>
  <result pre="of universal vaccines that provide protection against multiple subtypes of" exact="influenza" post="viruses. Current studies are mainly focused on identifying conserved"/>
  <result pre="influenza viruses. Current studies are mainly focused on identifying conserved" exact="influenza" post="epitopes, and the highly conserved HA stem has been"/>
  <result pre="to improve the effectiveness of universal vaccines. The current licensed" exact="influenza" post="vaccine products have several limitations. Although the live-attenuated and"/>
  <result pre="immune responses [178]. Immunogenicity has been a major concern for" exact="influenza" post="vaccine development. Novel types of vaccines, such as recombinant"/>
  <result pre="agonist, has been shown to increase the effectiveness of recombinant" exact="influenza" post="vaccines [180,181]. Similarly, the inclusion of a RIG-I agonist"/>
  <result pre="of a RIG-I agonist increases humoral immune responses to DNA" exact="influenza" post="vaccines [182], suggesting that innate sensor agonists can improve"/>
  <result pre="sensor agonists can improve the immunogenicity of new types of" exact="influenza" post="vaccines. In order to overcome the limitations of traditional"/>
  <result pre="In order to overcome the limitations of traditional and emerging" exact="influenza" post="vaccines, it is necessary to first understand the complex"/>
  <result pre="interplay between host immune responses and the pathologic mechanisms of" exact="influenza" post="viruses. The lack of proofreading ability in the viral"/>
  <result pre="antiviral resistance. At present, there are three classes of FDA-approved" exact="influenza" post="drugs targeting the influenza virus replication cycle. While these"/>
  <result pre="there are three classes of FDA-approved influenza drugs targeting the" exact="influenza" post="virus replication cycle. While these drugs are currently effective,"/>
  <result pre="drugs are effective at reducing the risk and severity of" exact="influenza" post="infection. However, there is still room for improvement. Advancing"/>
  <result pre="References References 1.BarrI.G.McCauleyJ.CoxN.DanielsR.EngelhardtO.G.FukudaK.GrohmannG.HayA.KelsoA.KlimovA.et al.Epidemiological, antigenic and genetic characteristics of seasonal" exact="influenza" post="A(H1N1), A(H3N2) and B influenza viruses: Basis for the"/>
  <result pre="and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B" exact="influenza" post="viruses: Basis for the WHO recommendation on the composition"/>
  <result pre="viruses: Basis for the WHO recommendation on the composition of" exact="influenza" post="vaccines for use in the 2009–2010 northern hemisphere seasonVaccine2010281156116710.1016/j.vaccine.2009.11.04320004635"/>
  <result pre="of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the" exact="influenza" post="virus polymerase PA subunitAntivir. Res.201816010911710.1016/j.antiviral.2018.10.00830316915 5.VijaykrishnaD.PoonL.L.ZhuH.C.MaS.K.LiO.T.CheungC.L.SmithG.J.PeirisJ.S.GuanY.Reassortment of pandemic H1N1/2009"/>
  <result pre="influenza virus polymerase PA subunitAntivir. Res.201816010911710.1016/j.antiviral.2018.10.00830316915 5.VijaykrishnaD.PoonL.L.ZhuH.C.MaS.K.LiO.T.CheungC.L.SmithG.J.PeirisJ.S.GuanY.Reassortment of pandemic H1N1/2009" exact="influenza" post="A virus in swineScience2010328152910.1126/science.118913220558710 6.DawoodF.S.IulianoA.D.ReedC.MeltzerM.I.ShayD.K.ChengP.Y.BandaranayakeD.BreimanR.F.BrooksW.A.BuchyP.et al.Estimated global mortality associated"/>
  <result pre="mortality associated with the first 12 months of 2009 pandemic" exact="influenza" post="A H1N1 virus circulation: A modelling studyLancet Infect. Dis.20121268769510.1016/S1473-3099(12)70121-422738893"/>
  <result pre="H1N1 virus circulation: A modelling studyLancet Infect. Dis.20121268769510.1016/S1473-3099(12)70121-422738893 7.CheungT.K.PoonL.L.Biology of" exact="influenza" post="a virusAnn. N. Y. Acad. Sci.2007110212510.1196/annals.1408.00117470908 8.HayashidaH.TohH.KikunoR.MiyataT.Evolution of influenza"/>
  <result pre="of influenza a virusAnn. N. Y. Acad. Sci.2007110212510.1196/annals.1408.00117470908 8.HayashidaH.TohH.KikunoR.MiyataT.Evolution of" exact="influenza" post="virus genesMol. Biol. Evol.1985228930310.1093/oxfordjournals.molbev.a0403523870863 9.DucatezM.F.PelletierC.MeyerG.Influenza D virus in cattle,"/>
  <result pre="viral infection in swineSci. Rep.201771166010.1038/s41598-017-12012-328916759 12.WhiteS.K.MaW.McDanielC.J.GrayG.C.LednickyJ.A.Serologic evidence of exposure to" exact="influenza" post="D virus among persons with occupational contact with cattleJ."/>
  <result pre="contact with cattleJ. Clin. Virol.201681313310.1016/j.jcv.2016.05.01727294672 13.VirkR.K.JayakumarJ.MendenhallI.H.MoorthyM.LamP.LinsterM.LimJ.LinC.OonL.L.E.LeeH.K.et al.Divergent evolutionary trajectories of" exact="influenza" post="B viruses underlie their contemporaneous epidemic activityProc. Natl. Acad."/>
  <result pre="of Reporter Influenza B VirusesViruses20191173610.3390/v1108073631404985 15.Gutierrez-PizarrayaA.Perez-RomeroP.AlvarezR.AydilloT.A.Osorio-GomezG.Milara-IbanezC.SanchezM.PachonJ.CorderoE.Unexpected severity of cases of" exact="influenza" post="B infection in patients that required hospitalization during the"/>
  <result pre="Infect.20126542343010.1016/j.jinf.2012.07.00422820034 16.SuS.ChavesS.S.PerezA.D’MelloT.KirleyP.D.Yousey-HindesK.FarleyM.M.HarrisM.SharangpaniR.LynfieldR.et al.Comparing clinical characteristics between hospitalized adults with laboratory-confirmed" exact="influenza" post="A and B virus infectionClin. Infect. Dis.20145925225510.1093/cid/ciu26924748521 17.MosnierA.CainiS.DaviaudI.NauleauE.BuiT.T.DebostE.BedouretB.AgiusG.van der"/>
  <result pre="A and B Influenza Virus InfectionsPLoS ONE201510e013618610.1371/journal.pone.013618626325069 18.PingJ.LopesT.J.NeumannG.KawaokaY.Development of high-yield" exact="influenza" post="B virus vaccine virusesProc. Natl. Acad. Sci. USA2016113E8296E830510.1073/pnas.161653011327930325 19.BuiM.WillsE.G.HeleniusA.WhittakerG.R.Role"/>
  <result pre="virus vaccine virusesProc. Natl. Acad. Sci. USA2016113E8296E830510.1073/pnas.161653011327930325 19.BuiM.WillsE.G.HeleniusA.WhittakerG.R.Role of the" exact="influenza" post="virus M1 protein in nuclear export of viral ribonucleoproteinsJ."/>
  <result pre="nuclear export of viral ribonucleoproteinsJ. Virol.2000741781178610.1128/JVI.74.4.1781-1786.200010644350 20.PaleseP.TobitaK.UedaM.CompansR.W.Characterization of temperature sensitive" exact="influenza" post="virus mutants defective in neuraminidaseVirology19746139741010.1016/0042-6822(74)90276-14472498 21.KosikI.YewdellJ.W.Influenza Hemagglutinin and Neuraminidase:"/>
  <result pre="the viral life cycleYale J. Biol. Med.20098215315920027280 23.IwasakiA.PillaiP.S.Innate immunity to" exact="influenza" post="virus infectionNat. Rev. Immunol.20141431532810.1038/nri366524762827 24.SubbaraoK.JosephT.Scientific barriers to developing vaccines"/>
  <result pre="virus infectionNat. Rev. Immunol.20141431532810.1038/nri366524762827 24.SubbaraoK.JosephT.Scientific barriers to developing vaccines against" exact="avian influenza" post="virusesNat. Rev. Immunol.2007726727810.1038/nri205417363960 25.NelsonM.I.HolmesE.C.The evolution of epidemic influenzaNat. Rev."/>
  <result pre="infectionNat. Rev. Immunol.20141431532810.1038/nri366524762827 24.SubbaraoK.JosephT.Scientific barriers to developing vaccines against avian" exact="influenza" post="virusesNat. Rev. Immunol.2007726727810.1038/nri205417363960 25.NelsonM.I.HolmesE.C.The evolution of epidemic influenzaNat. Rev."/>
  <result pre="of human airway epithelium by human and avian strains of" exact="influenza" post="a virusJ. Virol.2006808060806810.1128/JVI.00384-0616873262 29.ReadingP.C.MillerJ.L.AndersE.M.Involvement of the mannose receptor in"/>
  <result pre="29.ReadingP.C.MillerJ.L.AndersE.M.Involvement of the mannose receptor in infection of macrophages by" exact="influenza" post="virusJ. Virol.2000745190519710.1128/JVI.74.11.5190-5197.200010799594 30.UphamJ.P.PickettD.IrimuraT.AndersE.M.ReadingP.C.Macrophage receptors for influenza A virus: Role"/>
  <result pre="infection of macrophages by influenza virusJ. Virol.2000745190519710.1128/JVI.74.11.5190-5197.200010799594 30.UphamJ.P.PickettD.IrimuraT.AndersE.M.ReadingP.C.Macrophage receptors for" exact="influenza" post="A virus: Role of the macrophage galactose-type lectin and"/>
  <result pre="lectin can function as an attachment and entry receptor for" exact="influenza" post="virusJ. Virol.2014881659167210.1128/JVI.02014-1324257596 32.HillaireM.L.NieuwkoopN.J.BoonA.C.de MutsertG.Vogelzang-van TrierumS.E.FouchierR.A.OsterhausA.D.RimmelzwaanG.F.Binding of DC-SIGN to the"/>
  <result pre="Virol.2014881659167210.1128/JVI.02014-1324257596 32.HillaireM.L.NieuwkoopN.J.BoonA.C.de MutsertG.Vogelzang-van TrierumS.E.FouchierR.A.OsterhausA.D.RimmelzwaanG.F.Binding of DC-SIGN to the hemagglutinin of" exact="influenza" post="A viruses supports virus replication in DC-SIGN expressing cellsPLoS"/>
  <result pre="ONE20138e5616410.1371/journal.pone.005616423424649 33.LondriganS.L.TurvilleS.G.TateM.D.DengY.M.BrooksA.G.ReadingP.C.N-linked glycosylation facilitates sialic acid-independent attachment and entry of" exact="influenza" post="A viruses into cells expressing DC-SIGN or L-SIGNJ. Virol.2011852990300010.1128/JVI.01705-1021191006"/>
  <result pre="cells expressing DC-SIGN or L-SIGNJ. Virol.2011852990300010.1128/JVI.01705-1021191006 34.WangS.F.HuangJ.C.LeeY.M.LiuS.J.ChanY.J.ChauY.P.ChongP.ChenY.M.DC-SIGN mediates avian H5N1" exact="influenza" post="virus infection in cis and in transBiochem. Biophys. Res."/>
  <result pre="in transBiochem. Biophys. Res. Commun.200837356156610.1016/j.bbrc.2008.06.07818593570 35.GillespieL.RoosendahlP.NgW.C.BrooksA.G.ReadingP.C.LondriganS.L.Endocytic function is critical for" exact="influenza" post="A virus infection via DC-SIGN and L-SIGNSci. Rep.201661942810.1038/srep1942826763587 36.Stencel-BaerenwaldJ.E.ReissK.ReiterD.M.StehleT.DermodyT.S.The"/>
  <result pre="sweet spot: Defining virus-sialic acid interactionsNat. Rev. Microbiol.20141273974910.1038/nrmicro334625263223 37.DasK.AraminiJ.M.MaL.C.KrugR.M.ArnoldE.Structures of" exact="influenza" post="A proteins and insights into antiviral drug targetsNat. Struct."/>
  <result pre="antiviral drug targetsNat. Struct. Mol. Biol.20101753053810.1038/nsmb.177920383144 38.LiS.SiebenC.LudwigK.HoferC.T.ChiantiaS.HerrmannA.EghiaianF.SchaapI.A.pH-Controlled two-step uncoating of" exact="influenza" post="virusBiophys. J.20141061447145610.1016/j.bpj.2014.02.01824703306 39.GrambasS.BennettM.S.HayA.J.Influence of amantadine resistance mutations on the"/>
  <result pre="on the pH regulatory function of the M2 protein of" exact="influenza" post="A virusesVirology199219154154910.1016/0042-6822(92)90229-I1448912 40.WangC.TakeuchiK.PintoL.H.LambR.A.Ion channel activity of influenza A virus"/>
  <result pre="M2 protein of influenza A virusesVirology199219154154910.1016/0042-6822(92)90229-I1448912 40.WangC.TakeuchiK.PintoL.H.LambR.A.Ion channel activity of" exact="influenza" post="A virus M2 protein: Characterization of the amantadine blockJ."/>
  <result pre="Characterization of the amantadine blockJ. Virol.1993675585559410.1128/JVI.67.9.5585-5594.19937688826 41.DiasA.BouvierD.CrepinT.McCarthyA.A.HartD.J.BaudinF.CusackS.RuigrokR.W.The cap-snatching endonuclease of" exact="influenza" post="virus polymerase resides in the PA subunitNature200945891491810.1038/nature0774519194459 42.GuilligayD.TarendeauF.Resa-InfanteP.ColomaR.CrepinT.SehrP.LewisJ.RuigrokR.W.OrtinJ.HartD.J.et al.The"/>
  <result pre="PA subunitNature200945891491810.1038/nature0774519194459 42.GuilligayD.TarendeauF.Resa-InfanteP.ColomaR.CrepinT.SehrP.LewisJ.RuigrokR.W.OrtinJ.HartD.J.et al.The structural basis for cap binding by" exact="influenza" post="virus polymerase subunit PB2Nat. Struct. Mol. Biol.20081550050610.1038/nsmb.142118454157 43.BiswasS.K.NayakD.P.Mutational analysis"/>
  <result pre="Struct. Mol. Biol.20081550050610.1038/nsmb.142118454157 43.BiswasS.K.NayakD.P.Mutational analysis of the conserved motifs of" exact="influenza" post="A virus polymerase basic protein 1J. Virol.1994681819182610.1128/JVI.68.3.1819-1826.19948107244 44.UlmanenI.BroniB.A.KrugR.M.Role of"/>
  <result pre="polymerase basic protein 1J. Virol.1994681819182610.1128/JVI.68.3.1819-1826.19948107244 44.UlmanenI.BroniB.A.KrugR.M.Role of two of the" exact="influenza" post="virus core P proteins in recognizing cap 1 structures"/>
  <result pre="Acad. Sci. USA1981787355735910.1073/pnas.78.12.73556950380 45.PflugA.LukarskaM.Resa-InfanteP.ReichS.CusackS.Structural insights into RNA synthesis by the" exact="influenza" post="virus transcription-replication machineVirus Res.201723410311710.1016/j.virusres.2017.01.01328115197 46.FanH.WalkerA.P.CarriqueL.KeownJ.R.Serna MartinI.KariaD.SharpsJ.HengrungN.PardonE.SteyaertJ.et al.Structures of influenza"/>
  <result pre="the influenza virus transcription-replication machineVirus Res.201723410311710.1016/j.virusres.2017.01.01328115197 46.FanH.WalkerA.P.CarriqueL.KeownJ.R.Serna MartinI.KariaD.SharpsJ.HengrungN.PardonE.SteyaertJ.et al.Structures of" exact="influenza" post="A virus RNA polymerase offer insight into viral genome"/>
  <result pre="virus RNA polymerase offer insight into viral genome replicationNature201957328729010.1038/s41586-019-1530-731485076 47.EgorovA.BrandtS.SereinigS.RomanovaJ.FerkoB.KatingerD.GrassauerA.AlexandrovaG.KatingerH.MusterT.Transfectant" exact="influenza" post="A viruses with long deletions in the NS1 protein"/>
  <result pre="gene replicates in interferon-deficient systemsVirology199825232433010.1006/viro.1998.95089878611 49.KochsG.Garcia-SastreA.Martinez-SobridoL.Multiple anti-interferon actions of the" exact="influenza" post="A virus NS1 proteinJ. Virol.2007817011702110.1128/JVI.02581-0617442719 50.FortesP.BelosoA.OrtinJ.Influenza virus NS1 protein"/>
  <result pre="inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transportEMBO J.19941370471210.1002/j.1460-2075.1994.tb06310.x8313914 51.QiuY.KrugR.M.The" exact="influenza" post="virus NS1 protein is a poly(A)-binding protein that inhibits"/>
  <result pre="nuclear export of mRNAs containing poly(A)J. Virol.1994682425243210.1128/JVI.68.4.2425-2432.19947908060 52.ZhangK.XieY.Munoz-MorenoR.WangJ.ZhangL.EsparzaM.Garcia-SastreA.FontouraB.M.A.RenY.Structural basis for" exact="influenza" post="virus NS1 protein block of mRNA nuclear exportNat. Microbiol.201941671167910.1038/s41564-019-0482-x31263181"/>
  <result pre="of NLRP3 Inflammasome-Mediated Interleukin-1beta SecretionJ. Virol.2016904105411410.1128/JVI.00120-1626865721 54.RuckleA.HaasbachE.JulkunenI.PlanzO.EhrhardtC.LudwigS.The NS1 protein of" exact="influenza" post="A virus blocks RIG-I-mediated activation of the noncanonical NF-kappaB"/>
  <result pre="I-mediated induction of beta interferon by the NS1 protein of" exact="influenza" post="A virusJ. Virol.20078151452410.1128/JVI.01265-0617079289 57.GuoZ.ChenL.M.ZengH.GomezJ.A.PlowdenJ.FujitaT.KatzJ.M.DonisR.O.SambharaS.NS1 protein of influenza A virus"/>
  <result pre="NS1 protein of influenza A virusJ. Virol.20078151452410.1128/JVI.01265-0617079289 57.GuoZ.ChenL.M.ZengH.GomezJ.A.PlowdenJ.FujitaT.KatzJ.M.DonisR.O.SambharaS.NS1 protein of" exact="influenza" post="A virus inhibits the function of intracytoplasmic pathogen sensor,"/>
  <result pre="vRNP nuclear export through NES-independent interaction with hCRM1EMBO J.2000196751675810.1093/emboj/19.24.675111118210 59.O’NeillR.E.TalonJ.PaleseP.The" exact="influenza" post="virus NEP (NS2 protein) mediates the nuclear export of"/>
  <result pre="proton-translocating ATPase, at the plasma membrane is critical for efficient" exact="influenza" post="virus buddingProc. Natl. Acad. Sci. USA20121094615462010.1073/pnas.111472810922393008 61.McAuleyJ.L.TateM.D.MacKenzie-KludasC.J.PinarA.ZengW.StutzA.LatzE.BrownL.E.MansellA.Activation of the"/>
  <result pre="UAP56 is required for prevention of double-stranded RNA formation during" exact="influenza" post="A virus infectionJ. Virol.2011858646865510.1128/JVI.02559-1021680511 64.PichlmairA.SchulzO.TanC.P.NaslundT.I.LiljestromP.WeberF.Reis e SousaC.RIG-I-mediated antiviral responses"/>
  <result pre="USA20041013533353810.1073/pnas.030849610114982987 67.Le GofficR.BalloyV.LagranderieM.AlexopoulouL.EscriouN.FlavellR.ChignardM.Si-TaharM.Detrimental contribution of the Toll-like receptor (TLR)3 to" exact="influenza" post="A virus-induced acute pneumoniaPLoS Pathog.20062e5310.1371/journal.ppat.002005316789835 68.HeerA.K.ShamshievA.DondaA.UematsuS.AkiraS.KopfM.MarslandB.J.TLR signaling fine-tunes anti-influenza"/>
  <result pre="responses by means of TLR7-mediated recognition of single-stranded RNAScience20043031529153110.1126/science.109361614976261 70.PangI.K.PillaiP.S.IwasakiA.Efficient" exact="influenza" post="A virus replication in the respiratory tract requires signals"/>
  <result pre="Virus Infection and VaccinationJ. Immunol.20071794711472010.4049/jimmunol.179.7.471117878370 75.Jeisy-ScottV.KimJ.H.DavisW.G.CaoW.KatzJ.M.SambharaS.TLR7 recognition is dispensable for" exact="influenza" post="virus A infection but important for the induction of"/>
  <result pre="vaccine in miceJ. Virol.201286109881099810.1128/JVI.01064-1222837197 76.SeoS.U.KwonH.J.SongJ.H.ByunY.H.SeongB.L.KawaiT.AkiraS.KweonM.N.MyD88 signaling is indispensable for primary" exact="influenza" post="A virus infection but dispensable for secondary infectionJ. Virol.201084127131272210.1128/JVI.01675-1020943980"/>
  <result pre="cytoplasmic stress granule formationFASEB J.2012261629163910.1096/fj.11-19691522202676 79.MokB.W.SongW.WangP.TaiH.ChenY.ZhengM.WenX.LauS.Y.WuW.L.MatsumotoK.et al.The NS1 protein of" exact="influenza" post="A virus interacts with cellular processing bodies and stress"/>
  <result pre="Commun.20145471310.1038/ncomms571325140902 83.AllenI.C.ScullM.A.MooreC.B.HollE.K.McElvania-TeKippeE.TaxmanD.J.GuthrieE.H.PicklesR.J.TingJ.P.The NLRP3 inflammasome mediates in vivo innate immunity to" exact="influenza" post="A virus through recognition of viral RNAImmunity20093055656510.1016/j.immuni.2009.02.00519362020 84.ThomasP.G.DashP.AldridgeJ.R.Jr.EllebedyA.H.ReynoldsC.FunkA.J.MartinW.J.LamkanfiM.WebbyR.J.BoydK.L.et al.The"/>
  <result pre="intracellular sensor NLRP3 mediates key innate and healing responses to" exact="influenza" post="A virus via the regulation of caspase-1Immunity20093056657510.1016/j.immuni.2009.02.00619362023 85.IchinoheT.LeeH.K.OguraY.FlavellR.IwasakiA.Inflammasome recognition"/>
  <result pre="A virus via the regulation of caspase-1Immunity20093056657510.1016/j.immuni.2009.02.00619362023 85.IchinoheT.LeeH.K.OguraY.FlavellR.IwasakiA.Inflammasome recognition of" exact="influenza" post="virus is essential for adaptive immune responsesJ. Exp. Med.2009206798710.1084/jem.2008166719139171"/>
  <result pre="cellsVirology20063459610410.1016/j.virol.2005.09.04316253303 95.WareingM.D.LyonA.InglisC.GiannoniF.CharoI.SarawarS.R.Chemokine regulation of the inflammatory response to a low-dose" exact="influenza" post="infection in CCR2-/- miceJ. Leukoc. Biol.20078179380110.1189/jlb.050629917179466 96.WareingM.D.LyonA.B.LuB.GerardC.SarawarS.R.Chemokine expression during"/>
  <result pre="the development and resolution of a pulmonary leukocyte response to" exact="influenza" post="A virus infection in miceJ. Leukoc. Biol.20047688689510.1189/jlb.120364415240757 97.MandelboimO.LiebermanN.LevM.PaulL.ArnonT.I.BushkinY.DavisD.M.StromingerJ.L.YewdellJ.W.PorgadorA.Recognition of"/>
  <result pre="are involved in the interaction with hemagglutinin type 1 of" exact="influenza" post="virusJ. Virol.2010843789379710.1128/JVI.01815-0920147410 100.JegaskandaS.VandervenH.A.TanH.X.AlcantaraS.WraggK.M.ParsonsM.S.ChungA.W.JunoJ.A.KentS.J.Influenza Virus Infection Enhances Antibody-Mediated NK Cell"/>
  <result pre="PathwaysJ. Virol.20199310.1128/JVI.02090-18 101.HwangI.ScottJ.M.KakarlaT.DuriancikD.M.ChoiS.ChoC.LeeT.ParkH.FrenchA.R.BeliE.et al.Activation mechanisms of natural killer cells during" exact="influenza" post="virus infectionPLoS ONE20127e5185810.1371/journal.pone.005185823300570 102.CooperG.E.OstridgeK.KhakooS.I.WilkinsonT.M.A.StaplesK.J.Human CD49a(+) Lung Natural Killer Cell"/>
  <result pre="103.NogusaS.RitzB.W.KassimS.H.JenningsS.R.GardnerE.M.Characterization of age-related changes in natural killer cells during primary" exact="influenza" post="infection in miceMech. Ageing Dev.200812922323010.1016/j.mad.2008.01.00318304606 104.LiuB.MoriI.HossainM.J.DongL.TakedaK.KimuraY.Interleukin-18 improves the early"/>
  <result pre="miceMech. Ageing Dev.200812922323010.1016/j.mad.2008.01.00318304606 104.LiuB.MoriI.HossainM.J.DongL.TakedaK.KimuraY.Interleukin-18 improves the early defence system against" exact="influenza" post="virus infection by augmenting natural killer cell-mediated cytotoxicityJ. Gen."/>
  <result pre="cell-mediated cytotoxicityJ. Gen. Virol.20048542342810.1099/vir.0.19596-014769900 105.ZhouG.JuangS.W.KaneK.P.NK cells exacerbate the pathology of" exact="influenza" post="virus infection in miceEur. J. Immunol.20134392993810.1002/eji.20124262023436540 106.Abdul-CareemM.F.MianM.F.YueG.GillgrassA.ChenowethM.J.BarraN.G.ChewM.V.ChanT.Al-GarawiA.A.JordanaM.et al.Critical role"/>
  <result pre="al.Critical role of natural killer cells in lung immunopathology during" exact="influenza" post="infection in miceJ. Infect. Dis.201220616717710.1093/infdis/jis34022561366 107.HashimotoY.MokiT.TakizawaT.ShiratsuchiA.NakanishiY.Evidence for phagocytosis of"/>
  <result pre="influenza infection in miceJ. Infect. Dis.201220616717710.1093/infdis/jis34022561366 107.HashimotoY.MokiT.TakizawaT.ShiratsuchiA.NakanishiY.Evidence for phagocytosis of" exact="influenza" post="virus-infected, apoptotic cells by neutrophils and macrophages in miceJ."/>
  <result pre="Neutrophils in Viral Respiratory DiseaseFront. Immunol.2017855010.3389/fimmu.2017.0055028553293 109.TumpeyT.M.Garcia-SastreA.TaubenbergerJ.K.PaleseP.SwayneD.E.Pantin-JackwoodM.J.Schultz-CherryS.SolorzanoA.Van RooijenN.KatzJ.M.et al.Pathogenicity of" exact="influenza" post="viruses with genes from the 1918 pandemic virus: Functional"/>
  <result pre="of neutrophils in the upper and lower respiratory tract during" exact="influenza" post="virus infection of miceRespir. Res.200895710.1186/1465-9921-9-5718671884 111.TateM.D.BrooksA.G.ReadingP.C.MinternJ.D.Neutrophils sustain effective CD8(+)"/>
  <result pre="sustain effective CD8(+) T-cell responses in the respiratory tract following" exact="influenza" post="infectionImmunol. Cell Biol.20129019720510.1038/icb.2011.2621483446 112.LimK.HyunY.M.Lambert-EmoK.CapeceT.BaeS.MillerR.TophamD.J.KimM.Neutrophil trails guide influenza-specific CD8(+) T"/>
  <result pre="systems analysis identifies a feedforward inflammatory circuit leading to lethal" exact="influenza" post="infectionCell201315419721210.1016/j.cell.2013.06.01323827683 114.TrapnellB.C.WhitsettJ.A.Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated"/>
  <result pre="RooijenN.BrooksA.G.ReadingP.C.Critical role of airway macrophages in modulating disease severity during" exact="influenza" post="virus infection of miceJ. Virol.2010847569758010.1128/JVI.00291-1020504924 117.SchneiderC.NobsS.P.HeerA.K.KurrerM.KlinkeG.van RooijenN.VogelJ.KopfM.Alveolar macrophages are"/>
  <result pre="miceJ. Virol.2010847569758010.1128/JVI.00291-1020504924 117.SchneiderC.NobsS.P.HeerA.K.KurrerM.KlinkeG.van RooijenN.VogelJ.KopfM.Alveolar macrophages are essential for protection from" exact="respiratory failure" post="and associated morbidity following influenza virus infectionPLoS Pathog.201410e100405310.1371/journal.ppat.100405324699679 118.PurnamaC.NgS.L.TetlakP.SetiaganiY.A.KandasamyM.BaalasubramanianS.KarjalainenK.RuedlC.Transient"/>
  <result pre="essential for protection from respiratory failure and associated morbidity following" exact="influenza" post="virus infectionPLoS Pathog.201410e100405310.1371/journal.ppat.100405324699679 118.PurnamaC.NgS.L.TetlakP.SetiaganiY.A.KandasamyM.BaalasubramanianS.KarjalainenK.RuedlC.Transient ablation of alveolar macrophages leads"/>
  <result pre="118.PurnamaC.NgS.L.TetlakP.SetiaganiY.A.KandasamyM.BaalasubramanianS.KarjalainenK.RuedlC.Transient ablation of alveolar macrophages leads to massive pathology of" exact="influenza" post="infection without affecting cellular adaptive immunityEur. J. Immunol.2014442003201210.1002/eji.20134435924687623 119.CardaniA.BoultonA.KimT.S.BracialeT.J.Alveolar"/>
  <result pre="T cells by exogenous cell-associated antigensImmunity20021721122010.1016/S1074-7613(02)00365-512196292 121.GeurtsvanKesselC.H.WillartM.A.van RijtL.S.MuskensF.KoolM.BaasC.ThielemansK.BennettC.ClausenB.E.HoogstedenH.C.et al.Clearance of" exact="influenza" post="virus from the lung depends on migratory langerin+CD11b- but"/>
  <result pre="VivoFront. Immunol.20178141910.3389/fimmu.2017.0141929163495 126.HaoX.KimT.S.BracialeT.J.Differential response of respiratory dendritic cell subsets to" exact="influenza" post="virus infectionJ. Virol.2008824908491910.1128/JVI.02367-0718353940 127.HelftJ.ManicassamyB.GuermonprezP.HashimotoD.SilvinA.AgudoJ.BrownB.D.SchmolkeM.MillerJ.C.LeboeufM.et al.Cross-presenting CD103+ dendritic cells are"/>
  <result pre="infectionJ. Virol.2008824908491910.1128/JVI.02367-0718353940 127.HelftJ.ManicassamyB.GuermonprezP.HashimotoD.SilvinA.AgudoJ.BrownB.D.SchmolkeM.MillerJ.C.LeboeufM.et al.Cross-presenting CD103+ dendritic cells are protected from" exact="influenza" post="virus infectionJ. Clin. Investig.20121224037404710.1172/JCI6065923041628 128.WaithmanJ.ZankerD.XiaoK.OveissiS.WylieB.NgR.TogelL.ChenW.Resident CD8(+) and migratory CD103(+)"/>
  <result pre="CD103(+) dendritic cells control CD8 T cell immunity during acute" exact="influenza" post="infectionPLoS ONE20138e6613610.1371/journal.pone.006613623750278 129.NgS.L.TeoY.J.SetiaganiY.A.KarjalainenK.RuedlC.Type 1 Conventional CD103(+) Dendritic Cells Control"/>
  <result pre="replaces pattern-recognition receptors in promoting CD8(+) T cell responses to" exact="influenza" post="A virusNat. Immunol.20131424625310.1038/ni.251423314004 131.HoA.W.PrabhuN.BettsR.J.GeM.Q.DaiX.HutchinsonP.E.LewF.C.WongK.L.HansonB.J.MacaryP.A.et al.Lung CD103+ dendritic cells efficiently"/>
  <result pre="A virusNat. Immunol.20131424625310.1038/ni.251423314004 131.HoA.W.PrabhuN.BettsR.J.GeM.Q.DaiX.HutchinsonP.E.LewF.C.WongK.L.HansonB.J.MacaryP.A.et al.Lung CD103+ dendritic cells efficiently transport" exact="influenza" post="virus to the lymph node and load viral antigen"/>
  <result pre="dendritic cells regulate CD8(+) T-cell differentiation and memory responses in" exact="influenza" post="infectionMucosal Immunol.2019121025103710.1038/s41385-019-0173-131089186 138.WonH.Y.LeeJ.Y.RyuD.KimH.T.ChangS.Y.The Role of Plasmacytoid Dendritic Cells in"/>
  <result pre="Gut HealthImmune Netw.201919e610.4110/in.2019.19.e630838161 139.WolfA.I.BuehlerD.HensleyS.E.CavanaghL.L.WherryE.J.KastnerP.ChanS.WeningerW.Plasmacytoid dendritic cells are dispensable during primary" exact="influenza" post="virus infectionJ. Immunol.200918287187910.4049/jimmunol.182.2.87119124730 140.LuiG.ManchesO.AngelJ.MolensJ.P.ChaperotL.PlumasJ.Plasmacytoid dendritic cells capture and cross-present"/>
  <result pre="Cell ResponseJ. Virol.2015902830283710.1128/JVI.02546-1526719269 142.CruzJ.L.Perez-GironJ.V.LudtkeA.Gomez-MedinaS.RuibalP.IdoyagaJ.Munoz-FontelaC.Monocyte-derived dendritic cells enhance protection against secondary" exact="influenza" post="challenge by controlling the switch in CD8(+) T-cell immunodominanceEur."/>
  <result pre="143.WuH.HaistV.BaumgartnerW.SchughartK.Sustained viral load and late death in Rag2-/- mice after" exact="influenza" post="A virus infectionVirol. J.2010717210.1186/1743-422X-7-17220667098 144.PalladinoG.MozdzanowskaK.WashkoG.GerhardW.Virus-neutralizing antibodies of immunoglobulin G"/>
  <result pre="(IgG) but not of IgM or IgA isotypes can cure" exact="influenza" post="virus pneumonia in SCID miceJ. Virol.1995692075208110.1128/JVI.69.4.2075-2081.19957884853 145.BrownD.M.LeeS.Garcia-Hernandez MdeL.SwainS.L.Multifunctional CD4"/>
  <result pre="not of IgM or IgA isotypes can cure influenza virus" exact="pneumonia" post="in SCID miceJ. Virol.1995692075208110.1128/JVI.69.4.2075-2081.19957884853 145.BrownD.M.LeeS.Garcia-Hernandez MdeL.SwainS.L.Multifunctional CD4 cells expressing"/>
  <result pre="cells expressing gamma interferon and perforin mediate protection against lethal" exact="influenza" post="virus infectionJ. Virol.2012866792680310.1128/JVI.07172-1122491469 146.BrownD.M.DilzerA.M.MeentsD.L.SwainS.L.CD4 T Cell-Mediated Protection from Lethal"/>
  <result pre="PunchJ. Immunol.20061772888289810.4049/jimmunol.177.5.288816920924 147.BaumgarthN.KelsoA.In vivo blockade of gamma interferon affects the" exact="influenza" post="virus-induced humoral and the local cellular immune response in"/>
  <result pre="150.HuaL.YaoS.PhamD.JiangL.WrightJ.SawantD.DentA.L.BracialeT.J.KaplanM.H.SunJ.Cytokine-dependent induction of CD4+ T cells with cytotoxic potential during" exact="influenza" post="virus infectionJ. Virol.201387118841189310.1128/JVI.01461-1323986597 151.BettsR.J.PrabhuN.HoA.W.LewF.C.HutchinsonP.E.RotzschkeO.MacaryP.A.KemenyD.M.Influenza A virus infection results in"/>
  <result pre="Commun.20145349510.1038/ncomms449524633065 154.BelzG.T.XieW.AltmanJ.D.DohertyP.C.A previously unrecognized H-2D(b)-restricted peptide prominent in the primary" exact="influenza" post="A virus-specific CD8(+) T-cell response is much less apparent"/>
  <result pre="T cells have delayed viral clearance and increased mortality after" exact="influenza" post="virus challengeJ. Exp. Med.19921751143114510.1084/jem.175.4.11431552285 156.KreijtzJ.H.FouchierR.A.RimmelzwaanG.F.Immune responses to influenza virus"/>
  <result pre="mortality after influenza virus challengeJ. Exp. Med.19921751143114510.1084/jem.175.4.11431552285 156.KreijtzJ.H.FouchierR.A.RimmelzwaanG.F.Immune responses to" exact="influenza" post="virus infectionVirus Res.2011162193010.1016/j.virusres.2011.09.02221963677 157.BrincksE.L.KatewaA.KucabaT.A.GriffithT.S.LeggeK.L.CD8 T cells utilize TRAIL to"/>
  <result pre="virus infectionVirus Res.2011162193010.1016/j.virusres.2011.09.02221963677 157.BrincksE.L.KatewaA.KucabaT.A.GriffithT.S.LeggeK.L.CD8 T cells utilize TRAIL to control" exact="influenza" post="virus infectionJ. Immunol.20081814918492510.4049/jimmunol.181.7.491818802095 158.KimC.W.YooH.J.ParkJ.H.OhJ.E.LeeH.K.Exogenous Interleukin-33 Contributes to Protective Immunity"/>
  <result pre="InfectionsFront. Immunol.2018967810.3389/fimmu.2018.0067829686673 161.SunJ.MadanR.KarpC.L.BracialeT.J.Effector T cells control lung inflammation during acute" exact="influenza" post="virus infection by producing IL-10Nat. Med.20091527728410.1038/nm.192919234462 162.GrahamM.B.BracialeT.J.Resistance to and"/>
  <result pre="by producing IL-10Nat. Med.20091527728410.1038/nm.192919234462 162.GrahamM.B.BracialeT.J.Resistance to and recovery from lethal" exact="influenza" post="virus infection in B lymphocyte-deficient miceJ. Exp. Med.19971862063206810.1084/jem.186.12.20639396777 163.LeeB.O.Rangel-MorenoJ.Moyron-QuirozJ.E.HartsonL.MakrisM.SpragueF.LundF.E.RandallT.D.CD4"/>
  <result pre="Med.19971862063206810.1084/jem.186.12.20639396777 163.LeeB.O.Rangel-MorenoJ.Moyron-QuirozJ.E.HartsonL.MakrisM.SpragueF.LundF.E.RandallT.D.CD4 T cell-independent antibody response promotes resolution of primary" exact="influenza" post="infection and helps to prevent reinfectionJ. Immunol.20051755827583810.4049/jimmunol.175.9.582716237075 164.WaffarnE.E.BaumgarthN.Protective B"/>
  <result pre="B cell responses to flu--no fluke!J. Immunol.20111863823382910.4049/jimmunol.100209021422252 165.TamuraS.KurataT.Defense mechanisms against" exact="influenza" post="virus infection in the respiratory tract mucosaJpn. J. Infect."/>
  <result pre="mucosaJpn. J. Infect. Dis.20045723624715623947 166.HensleyS.E.DasS.R.BaileyA.L.SchmidtL.M.HickmanH.D.JayaramanA.ViswanathanK.RamanR.SasisekharanR.BenninkJ.R.et al.Hemagglutinin receptor binding avidity drives" exact="influenza" post="A virus antigenic driftScience200932673473610.1126/science.117825819900932 167.NeuK.E.Henry DunandC.J.WilsonP.C.Heads, stalks and everything"/>
  <result pre="167.NeuK.E.Henry DunandC.J.WilsonP.C.Heads, stalks and everything else: How can antibodies eradicate" exact="influenza" post="as a human disease?Curr. Opin. Immunol.201642485510.1016/j.coi.2016.05.01227268395 168.AngelettiD.GibbsJ.S.AngelM.KosikI.HickmanH.D.FrankG.M.DasS.R.WheatleyA.K.PrabhakaranM.LeggatD.J.et al.Defining B"/>
  <result pre="B cell immunodominance to virusesNat. Immunol.20171845646310.1038/ni.368028192417 169.van de SandtC.E.KreijtzJ.H.RimmelzwaanG.F.Evasion of" exact="influenza" post="A viruses from innate and adaptive immune responsesViruses201241438147610.3390/v409143823170167 170.TreanorJ.J.TierneyE.L.ZebedeeS.L.LambR.A.MurphyB.R.Passively"/>
  <result pre="responsesViruses201241438147610.3390/v409143823170167 170.TreanorJ.J.TierneyE.L.ZebedeeS.L.LambR.A.MurphyB.R.Passively transferred monoclonal antibody to the M2 protein inhibits" exact="influenza" post="A virus replication in miceJ. Virol.1990641375137710.1128/JVI.64.3.1375-1377.19902304147 171.CarragherD.M.KaminskiD.A.MoquinA.HartsonL.RandallT.D.A novel role"/>
  <result pre="role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to" exact="influenza" post="virusJ. Immunol.20081814168417610.4049/jimmunol.181.6.416818768874 172.JegaskandaS.WeinfurterJ.T.FriedrichT.C.KentS.J.Antibody-dependent cellular cytotoxicity is associated with control"/>
  <result pre="172.JegaskandaS.WeinfurterJ.T.FriedrichT.C.KentS.J.Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1" exact="influenza" post="virus infection of macaquesJ. Virol.2013875512552210.1128/JVI.03030-1223468501 173.ChoiY.S.BaumgarthN.Dual role for B-1a"/>
  <result pre="macaquesJ. Virol.2013875512552210.1128/JVI.03030-1223468501 173.ChoiY.S.BaumgarthN.Dual role for B-1a cells in immunity to" exact="influenza" post="virus infectionJ. Exp. Med.20082053053306410.1084/jem.2008097919075288 174.PutriW.MuscatelloD.J.StockwellM.S.NewallA.T.Economic burden of seasonal influenza"/>
  <result pre="to influenza virus infectionJ. Exp. Med.20082053053306410.1084/jem.2008097919075288 174.PutriW.MuscatelloD.J.StockwellM.S.NewallA.T.Economic burden of seasonal" exact="influenza" post="in the United StatesVaccine2018363960396610.1016/j.vaccine.2018.05.05729801998 175.PagetJ.SpreeuwenbergP.CharuV.TaylorR.J.IulianoA.D.BreseeJ.SimonsenL.ViboudC.collab: Global Seasonal Influenza-associated Mortality"/>
  <result pre="Mortality Collaborator Networkcollab: GLaMOR Collaborating TeamsGlobal mortality associated with seasonal" exact="influenza" post="epidemics: New burden estimates and predictors from the GLaMOR"/>
  <result pre="Stem Domain From Influenza HemagglutininFront. Immunol.20201143110.3389/fimmu.2020.0043132269566 178.HoftD.F.BabusisE.WorkuS.SpencerC.T.LottenbachK.TruscottS.M.AbateG.SakalaI.G.EdwardsK.M.CreechC.B.et al.Live and inactivated" exact="influenza" post="vaccines induce similar humoral responses, but only live vaccines"/>
  <result pre="responses in young childrenJ. Infect. Dis.201120484585310.1093/infdis/jir43621846636 179.SoemaP.C.KompierR.AmorijJ.P.KerstenG.F.Current and next generation" exact="influenza" post="vaccines: Formulation and production strategiesEur. J. Pharm. Biopharm.20159425126310.1016/j.ejpb.2015.05.02326047796 180.HuleattJ.W.NakaarV.DesaiP.HuangY.HewittD.JacobsA.TangJ.McDonaldW.SongL.EvansR.K.et"/>
  <result pre="Pharm. Biopharm.20159425126310.1016/j.ejpb.2015.05.02326047796 180.HuleattJ.W.NakaarV.DesaiP.HuangY.HewittD.JacobsA.TangJ.McDonaldW.SongL.EvansR.K.et al.Potent immunogenicity and efficacy of a universal" exact="influenza" post="vaccine candidate comprising a recombinant fusion protein linking influenza"/>
  <result pre="universal influenza vaccine candidate comprising a recombinant fusion protein linking" exact="influenza" post="M2e to the TLR5 ligand flagellinVaccine20082620121410.1016/j.vaccine.2007.10.06218063235 181.WangB.Z.GillH.S.HeC.OuC.WangL.WangY.C.FengH.ZhangH.PrausnitzM.R.CompansR.W.Microneedle delivery of"/>
  <result pre="an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective" exact="influenza" post="immunityJ. Control. Release20141781710.1016/j.jconrel.2014.01.00224417966 182.LukeJ.M.SimonG.G.SoderholmJ.ErrettJ.S.AugustJ.T.GaleM.Jr.HodgsonC.P.WilliamsJ.A.Coexpressed RIG-I agonist enhances humoral immune"/>
  <result pre="Control. Release20141781710.1016/j.jconrel.2014.01.00224417966 182.LukeJ.M.SimonG.G.SoderholmJ.ErrettJ.S.AugustJ.T.GaleM.Jr.HodgsonC.P.WilliamsJ.A.Coexpressed RIG-I agonist enhances humoral immune response to" exact="influenza" post="virus DNA vaccineJ. Virol.2011851370138310.1128/JVI.01250-1021106745 183.SheuT.G.DeydeV.M.Okomo-AdhiamboM.GartenR.J.XuX.BrightR.A.ButlerE.N.WallisT.R.KlimovA.I.GubarevaL.V.Surveillance for neuraminidase inhibitor resistance"/>
  <result pre="DNA vaccineJ. Virol.2011851370138310.1128/JVI.01250-1021106745 183.SheuT.G.DeydeV.M.Okomo-AdhiamboM.GartenR.J.XuX.BrightR.A.ButlerE.N.WallisT.R.KlimovA.I.GubarevaL.V.Surveillance for neuraminidase inhibitor resistance among human" exact="influenza" post="A and B viruses circulating worldwide from 2004 to"/>
  <result pre="neuraminidase inhibitors conferred by an R292K mutation in a human" exact="influenza" post="virus H7N9 isolate can be masked by a mixed"/>
  <result pre="masked by a mixed R/K viral populationmBio2013410.1128/mBio.00396-13 186.BurnhamA.J.BaranovichT.GovorkovaE.A.Neuraminidase inhibitors for" exact="influenza" post="B virus infection: Efficacy and resistanceAntivir. Res.201310052053410.1016/j.antiviral.2013.08.02324013000 Figure 1"/>
  <result pre="infection: Efficacy and resistanceAntivir. Res.201310052053410.1016/j.antiviral.2013.08.02324013000 Figure 1 The structure of" exact="influenza" post="A virus. IAV is a negative-stranded RNA virus belonging"/>
  <result pre="from host cells. Anti-influenza drugs inhibit various steps of the" exact="influenza" post="virus replication cycle. Figure 3 Overview of dendritic cell"/>
  <result pre="cell subsets in the lung and DC-mediated immune responses. After" exact="influenza" post="virus infection, viral antigen-captured cDCs migrate to lymph nodes"/>
 </snippets>
</snippetsTree>
